Back to Intelligence
#drug-manufacturing
(3 articles)Risk & Disruption
High ImpactJul 19, 2026100 Essential US Medicines Face Hidden Supply Chain Risks
A comprehensive CIDRAP analysis has identified hidden supply chain vulnerabilities affecting approximately 100 essential medicines in the United States. These risks stem from single-source dependencie
CIDRAP#pharmaceutical-supply-chain#medicine-shortage-risk#supply-chain-resilience
Risk & Disruption
ModerateJun 5, 2026Single-Use Manufacturing Risk Mitigation Strategies for Pharma
Single-use manufacturing systems have become critical infrastructure in biopharmaceutical production, yet their concentrated supplier base creates significant supply chain vulnerability. This article
Drug Discovery News#single-use-systems#pharma-supply-chain#risk-mitigation
Risk & Disruption
CriticalMay 6, 2026US Drug Supply Exposed: Critical China Dependency Risk
The US pharmaceutical supply chain faces a critical structural vulnerability stemming from significant dependency on China for active pharmaceutical ingredients (APIs) and drug manufacturing. This con
Washington Examiner#pharmaceutical-supply-chain#china-dependency#drug-manufacturing